Arbuckle Stuart A's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed May 18, 2022
- Accession no.
- 0000899243-22-018610
- Filed
- May 18, 2022
- Trade date
- May 16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions. Open-market sales total $33.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arbuckle Stuart ACIK 0001557290 | Officer (EVP, COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | Common Stock | SSaleDisposed | −11 | $246.21F2,F3 | −$2,708.31 | 64,882 | Direct | |
| May 16, 2022 | Common Stock | SSaleDisposed | −10 | $247.95 | −$2,479.5 | 64,872 | Direct | |
| May 16, 2022 | Common Stock | SSaleDisposed | −20 | $249.35F2,F4 | −$4,987 | 64,852 | Direct | |
| May 16, 2022 | Common Stock | SSaleDisposed | −32 | $250.78F2,F5 | −$8,024.96 | 64,820 | Direct | |
| May 16, 2022 | Common Stock | SSaleDisposed | −10 | $251.43 | −$2,514.3 | 64,810 | Direct | |
| May 16, 2022 | Common Stock | SSaleDisposed | −10 | $252.66 | −$2,526.6 | 64,800 | Direct | |
| May 16, 2022 | Common Stock | SSaleDisposed | −40 | $254.19F2,F6 | −$10,167.6 | 64,760 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 4 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $246.21 (range $245.78 to $246.25).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $249.35 (range $249.24 to $249.45).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $250.78 (range $250.35 to $250.97).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $254.19 (range $253.74 to $254.57).
Referenced by the price of 1 transaction in Table I.